Additional resources
Roche Breast cancer IHC/ISH portfolio, including market leading companion diagnostics
Our commitment to treating breast cancer includes over 25 assays, which can help accurately determine the tumor lineage and identify unsegmented patient populations that can help clinicians identify appropriate treatment options.
Sustainability in diagnostics
Together with our laboratory partners, we are on a journey toward a more sustainable future for the healthcare sector and for the planet we call home. This commitment is a key part of the broader Roche sustainability strategy, which supports laboratories in overcoming mounting pressures they face to reduce their environmental footprint without compromising diagnostic quality or operational efficiency.
Alzheimer’s disease testing
In the United States, over 6.9 million people live with Alzheimer’s disease (AD), and the number of cases is expected to rise to 13 million by 2050. At Roche, we are investigating diagnostics that can help with early Alzheimer’s detection.
Genomic profiling: A new era in cancer care
Finding the cancer tumor’s ‘fingerprint’ will help patients gain access to personalized healthcare.
navify® Digital Pathology
A flexible, end-to-end digital pathology solution designed to fit your lab and address your unique lab needs. navify Digital Pathology is an intuitive platform that enhances pathology workflow efficiency, freeing more time in the laboratory to focus on value-driven tasks with increasing ease.